GlassScriptPhysician profile
Merrill B Heddy
NPI 1558988527
$3,001.90
in general payments reported to CMS, 2019-2025
12 companies · $1,174 in 2025
The $1,174 reported for 2025 was more than what 83% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $867 · 2023: $495 · 2024: $466 · 2025: $1,174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,369 · Travel and Lodging: $766.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,369.16 |
| Travel and Lodging | $766.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,103.03 | 2023-2025 | |
| Stryker Corporation | $866.50 | 2022 | |
| Organogenesis INC. | $264.46 | 2023 | Puraply |
| Paratek Pharmaceuticals, INC. | $187.80 | 2023-2025 | Nuzyra |
| Next Science LLC | $153.88 | 2024 | Surgx, Blastx, Xperience |
| Davol INC. | $148.66 | 2023 | Arista Ah Flexitip |
| Linvatec Corporation | $122.89 | 2025 | Colink Afx, Biobrace 23mm, 5ms |
| Solventum Corporation | $79.01 | 2025 | Activ.A.C. |
| Smith+Nephew, INC. | $31.87 | 2025 | Bone Anchors With Arthroscopic Delivery System, Q-Fix |
| Pacira Pharmaceuticals Incorporated | $20.05 | 2025 | Exparel |
| Kerecis Limited | $12.96 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Musculoskeletal Transplant Foundation INC. | $10.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Merrill Heddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.